Similar articles for PMID: 29330297

Year	Number of Results
2008	4
2009	3
2010	4
2011	7
2012	7
2013	5
2014	14
2015	8
2016	17
2017	11
2018	19
2019	22
2020	18
2021	11
2022	10
2024	0

1

Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate.

Hasegawa T, Glavich GJ, Pahuski M, Short A, Semmes OJ, Yang L, Galkin V, Drake R, Esquela-Kerscher A. Hasegawa T, et al. Mol Cancer Res. 2018 Apr;16(4):669-681. doi: 10.1158/1541-7786.MCR-17-0321. Epub 2018 Jan 12. Mol Cancer Res. 2018. PMID: 29330297 Free PMC article.

2

microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.

Bhagirath D, Yang TL, Bucay N, Sekhon K, Majid S, Shahryari V, Dahiya R, Tanaka Y, Saini S. Bhagirath D, et al. Cancer Res. 2018 Apr 1;78(7):1833-1844. doi: 10.1158/0008-5472.CAN-17-2069. Epub 2018 Feb 1. Cancer Res. 2018. PMID: 29437039 Free PMC article.

3

miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.

Lewis H, Lance R, Troyer D, Beydoun H, Hadley M, Orians J, Benzine T, Madric K, Semmes OJ, Drake R, Esquela-Kerscher A. Lewis H, et al. Cell Cycle. 2014;13(2):227-39. doi: 10.4161/cc.26984. Epub 2013 Nov 7. Cell Cycle. 2014. PMID: 24200968 Free PMC article.

4

Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma.

Wang X, Wang X, Zhu Z, Li W, Yu G, Jia Z, Wang X. Wang X, et al. Biomed Pharmacother. 2019 Sep;117:109109. doi: 10.1016/j.biopha.2019.109109. Epub 2019 Jun 20. Biomed Pharmacother. 2019. PMID: 31229922 Free article.

5

Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.

Sánchez CA, Andahur EI, Valenzuela R, Castellón EA, Fullá JA, Ramos CG, Triviño JC. Sánchez CA, et al. Oncotarget. 2016 Jan 26;7(4):3993-4008. doi: 10.18632/oncotarget.6540. Oncotarget. 2016. PMID: 26675257 Free PMC article.

6

miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.

Gururajan M, Josson S, Chu GC, Lu CL, Lu YT, Haga CL, Zhau HE, Liu C, Lichterman J, Duan P, Posadas EM, Chung LW. Gururajan M, et al. Clin Cancer Res. 2014 Dec 15;20(24):6559-69. doi: 10.1158/1078-0432.CCR-14-1784. Epub 2014 Oct 16. Clin Cancer Res. 2014. PMID: 25324143 Free PMC article.

7

hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.

Xu B, Tao T, Wang Y, Fang F, Huang Y, Chen S, Zhu W, Chen M. Xu B, et al. Tumour Biol. 2016 Oct;37(10):14141-14151. doi: 10.1007/s13277-016-5196-6. Epub 2016 Aug 14. Tumour Biol. 2016. PMID: 27524492

8

The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.

Ottman R, Levy J, Grizzle WE, Chakrabarti R. Ottman R, et al. Oncotarget. 2016 Nov 8;7(45):73739-73753. doi: 10.18632/oncotarget.12061. Oncotarget. 2016. PMID: 27650539 Free PMC article.

9

MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.

Nam RK, Benatar T, Wallis CJ, Amemiya Y, Yang W, Garbens A, Naeim M, Sherman C, Sugar L, Seth A. Nam RK, et al. Prostate. 2016 Jul;76(10):869-84. doi: 10.1002/pros.23177. Epub 2016 Mar 15. Prostate. 2016. PMID: 26990571

10

Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.

Ling Z, Wang X, Tao T, Zhang L, Guan H, You Z, Lu K, Zhang G, Chen S, Wu J, Qian J, Liu H, Xu B, Chen M. Ling Z, et al. J Exp Clin Cancer Res. 2017 Nov 15;36(1):159. doi: 10.1186/s13046-017-0629-7. J Exp Clin Cancer Res. 2017. PMID: 29141691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

143 results

Results by year